APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Growth and Trends Forecast to 2032

27 December 202591 pages

Choose your research edition.

Industry ResearchPorcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine include Boehringer Ingelheim, Ceva, Merck, Pharmgate, Zoetis, SPAH, Huizhong Biological, Jiangsu Nannong Hi-Tech and Jinyu Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Company

Boehringer Ingelheim

Ceva

Merck

Pharmgate

Zoetis

SPAH

Huizhong Biological

Jiangsu Nannong Hi-Tech

Jinyu Biotechnology

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Segment by Type

One-dose Type

Two-dose Type

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Segment by Application

Piglet

Adult Pig

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of One-dose Type Table 2. Major Company of Two-dose Type Table 3. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Trends Table 25. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Drivers Table 26. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Opportunities and Challenges Table 27. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Restraints Table 28. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Share by Company (2021-2026) Table 32. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Major Company Production Sites and Headquarters Table 35. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Company, Product Type & Application Table 36. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Ceva Company Information Table 77. Ceva Business Overview Table 78. Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 80. Ceva Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 85. Merck Recent Development Table 86. Pharmgate Company Information Table 87. Pharmgate Business Overview Table 88. Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 90. Pharmgate Recent Development Table 91. Zoetis Company Information Table 92. Zoetis Business Overview Table 93. Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 95. Zoetis Recent Development Table 96. SPAH Company Information Table 97. SPAH Business Overview Table 98. SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 100. SPAH Recent Development Table 101. Huizhong Biological Company Information Table 102. Huizhong Biological Business Overview Table 103. Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 105. Huizhong Biological Recent Development Table 106. Jiangsu Nannong Hi-Tech Company Information Table 107. Jiangsu Nannong Hi-Tech Business Overview Table 108. Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 110. Jiangsu Nannong Hi-Tech Recent Development Table 111. Jinyu Biotechnology Company Information Table 112. Jinyu Biotechnology Business Overview Table 113. Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 115. Jinyu Biotechnology Recent Development Table 116. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 118. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2026) Table 119. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country (2021-2026) Table 124. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share Forecast by Country (2027-2032) Table 126. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 128. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2026) Table 129. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country (2021-2026) Table 134. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country (2021-2026) Table 144. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share Forecast by Country (2027-2032) Table 146. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2026) Table 149. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country (2021-2026) Table 154. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country (2021-2026) Table 164. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Distributors List Table 169. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Image Figure 2. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (2021-2032) & (K Units) Figure 5. One-dose Type Image Figure 6. Global One-dose Type Sales YoY Growth (2021-2032) & (K Units) Figure 7. Two-dose Type Image Figure 8. Global Two-dose Type Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Piglet Image Figure 24. Global Piglet Sales YoY Growth (2021-2032) & (K Units) Figure 25. Adult Pig Image Figure 26. Global Adult Pig Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • One-dose Type
  • Two-dose Type
Applications
  • Piglet
  • Adult Pig
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Merck
  • Pharmgate
  • Zoetis
  • SPAH
  • Huizhong Biological
  • Jiangsu Nannong Hi-Tech
  • Jinyu Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Type
  6. 1.3.1 One-dose Type
  7. 1.3.2 Two-dose Type
  8. 1.4 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Type
  9. 1.4.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Trends
  2. 2.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Drivers
  3. 2.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Opportunities and Challenges
  4. 2.4 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Price (2021-2026)
  4. 3.4 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Company, Product Type & Application
  7. 3.7 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Tier 1, Tier 2, and Tier 3
4 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Regional Status and Outlook
  1. 4.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Historic Market Size by Region
  3. 4.2.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine by Application
  1. 5.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Application
  2. 5.1.1 Piglet
  3. 5.1.2 Adult Pig
  4. 5.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Application
  5. 5.2.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Ceva
  8. 6.2.1 Ceva Company Information
  9. 6.2.2 Ceva Business Overview
  10. 6.2.3 Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  12. 6.2.5 Ceva Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Pharmgate
  20. 6.4.1 Pharmgate Company Information
  21. 6.4.2 Pharmgate Business Overview
  22. 6.4.3 Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  24. 6.4.5 Pharmgate Recent Developments
  25. 6.5 Zoetis
  26. 6.5.1 Zoetis Company Information
  27. 6.5.2 Zoetis Business Overview
  28. 6.5.3 Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  30. 6.5.5 Zoetis Recent Developments
  31. 6.6 SPAH
  32. 6.6.1 SPAH Company Information
  33. 6.6.2 SPAH Business Overview
  34. 6.6.3 SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  36. 6.6.5 SPAH Recent Developments
  37. 6.7 Huizhong Biological
  38. 6.7.1 Huizhong Biological Company Information
  39. 6.7.2 Huizhong Biological Business Overview
  40. 6.7.3 Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  42. 6.7.5 Huizhong Biological Recent Developments
  43. 6.8 Jiangsu Nannong Hi-Tech
  44. 6.8.1 Jiangsu Nannong Hi-Tech Company Information
  45. 6.8.2 Jiangsu Nannong Hi-Tech Business Overview
  46. 6.8.3 Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  48. 6.8.5 Jiangsu Nannong Hi-Tech Recent Developments
  49. 6.9 Jinyu Biotechnology
  50. 6.9.1 Jinyu Biotechnology Company Information
  51. 6.9.2 Jinyu Biotechnology Business Overview
  52. 6.9.3 Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  54. 6.9.5 Jinyu Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country
  2. 7.1.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
  6. 7.2.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country
  2. 8.1.1 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
  6. 8.2.1 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country
  2. 10.1.1 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
  6. 10.2.1 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Value Chain Analysis
  2. 12.1.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Production Mode & Process
  7. 12.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Distributors
  10. 12.2.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst